Medical net on July 27, 50 drugs were monitored, 22 first to be targeted!
On July 26, the anhui health and family planning commission issued the "key drug monitoring catalogue for 2017".
▍ 50 drug be monitored, doctors use more, to be supervision
Notify the municipal family planning departments of public health in anhui (the tube center) a month, according to directory, announced the roadmap, will in the first half of 2017 districts in public hospitals monitored drugs, purchasing amount of total purchase amount ratio for sorting.
To monitor and control the drug, carry out third-party prescription review, conduct supervision and notification of unreasonable drug use doctors and units, and discuss the head of the unit when necessary.
If the circumstances of unreasonable drug use are serious, the right of doctors shall be suspended according to the relevant provisions; For medical staff who have been notified twice in a row, the professional title review has been postponed for two years.
For the key monitoring catalogue, the anhui health and family planning commission said: in principle, the annual adjustment. But every quarter a prescription review of drugs and large quantities of drugs to be monitored, and the doctors who reported unreasonable use of drugs according to their dosage.
▍ 22 drug monitoring on the list for the first time
On August 30, 2016, the anhui health and family planning commission issued the "key drug monitoring catalogue for the first half of 2016". The number and category of the two catalogues have not changed, the same 50 drugs -- 20 at the bottom, 10 for antibiotics at the county level and 20 for non-antibiotics.
The difference is that 22 drugs are new faces.
By comparison, there are 9 units in the grass-roots directory, and 2 non-antibiotics and 11 drugs are monitored by anhui province for the first time. They are also familiar products, such as shu heming, ginseng and wheat, etc. It's a good time to "fall" and come up again.
▍ was monitored, drug sales
The anhui health and family planning commission revealed that the key monitoring catalogue originated from the data monitored by the centralized procurement platform in anhui province. The comparison between the two versions, which did not appear in the catalogue, showed that the results of the surveillance had been the result of a decline in sales.
The new list of 22 drugs is about to be tested.
Despite the power of focus monitoring, it is important to note that 28 drugs still remain in the two directories.
Attached: anhui "key drug control catalogue of 2017"
|
